Want to join the conversation?
Pharmaceutical company $MYL said it has launched in US its Finasteride Tablets USP, 1 mg, a generic version of $MRK's Propecia. $MYL received final approval from the US FDA for ANDA for this product, which is indicated for the treatment of male pattern hair loss.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.